Navigation Links
Novelos Therapeutics Prices $5.5 Million Public Offering
Date:2/13/2013

MADISON, Wis., Feb. 13, 2013 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced the pricing of a public offering of 11,000,000 units at $0.50 per unit for gross proceeds of $5,500,000.  Each unit consists of one share of our common stock, a Class A Warrant with a one-year term to purchase one-half of a share of our common stock at an exercise price of $0.50 per share and a Class B Warrant with a five-year term to purchase one share of our common stock at an exercise price of $0.50 per share.  Novelos expects to close the transaction, subject to customary conditions, on or about February 19, 2013.

Burrill Securities LLC is acting as a placement agent in a co-lead capacity for the offering.  Dawson James Securities, Inc. is acting as a sub-agent in a co-lead capacity.

The Benchmark Company, LLC is acting as a sub-agent.

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any offer or sale of these securities in any jurisdiction or to any person in any particular jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The offering will be made only by means of a prospectus supplement and accompanying prospectus, copies of which may be obtained from Burrill Securities LLC, Prospectus Department, One Embarcadero Center, Suite 2700, San Francisco, CA 94111, 415-591-5400 or email: ksheinerman@b-c.com.  Before any investment, an investor should read the prospectus supplement and the accompanying prospectus, including the information incorporated by reference therein, for more complete information about Novelos and this offering.

INVESTOR CONT
'/>"/>

SOURCE Novelos Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
2. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
3. Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29
4. Novelos Therapeutics Closes $2 Million Private Placement
5. Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
6. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
7. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
8. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
9. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
10. Novelos Therapeutics Prices $5.4 Million Public Offering
11. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... -- Tom Daulton, CEO of Mammotome, a division of Devicor Medical ... Cincinnati chapter of the Association for ... top executive who is also a breast cancer survivor, led ... March of 2010. Daulton will be presented with the award ... Bank, on May 22. The ACG Deal Maker ...
(Date:5/21/2013)... and PHILADELPHIA , May 21, 2013 /PRNewswire/ ... new corporate image and impressive new product developments at the ... . "After ten years of unerring focus on product literature ... the need to mark the occasion," said founding director ... have some interesting developments of benefit to our clients and ...
(Date:5/21/2013)... -- Zacks.com announces the list of stocks featured in the ... discuss the latest news and events impacting stocks and ... include Actavis, Inc.,s (NYSE: ACT ), BP plc ... ), Petrobras (NYSE: PBR ) and Devon Energy ... http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) Get the most recent ...
Breaking Medicine Technology:Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5
(Date:5/21/2013)... St. Petersburg, FL (PRWEB) May 22, 2013 ... Sale" of Cellulite Whisperer ® products has begun with ... it is tied to estrogen. Many women get the dreaded ... fatty deposits just beneath the skin where they have been ... appearance. While there are no easy fixes, a specific program ...
(Date:5/21/2013)... Daily Gossip Magazine published well-documented articles that are meant to ... on the latest weight loss methods by publishing weekly in-depth ... review of Kyle Leon’s Customized Fat Loss Plan ... lose weight or stay in shape with the minimum effort. ... by a popular fitness trainer, Kyle Leon, who has made ...
(Date:5/21/2013)... Primary care practice transformation on a large ... reform efforts aimed at achieving better outcomes, better ... evidence that transformation toward the patient-centered medical home ... care environment, the U.S. Department of Health and ... funded 14 studies to learn more about the ...
(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 HealthSmart ... Its expanding national presence has required the hiring of ... , HealthSmart is pleased to announce that Dawn Powell ... is serving as the Director of Account Management in ... Corporate offices in Irving, Texas. With extensive client management, ...
(Date:5/21/2013)... 21, 2013 According to a May 13, ... Use of Botox,” Botox injections have become the ... in 2002 (Go to goo.gl/8iYbD). Although it is mostly associated ... men. The injection makes facial wrinkles less visible by paralyzing ... for about three months. This means that people who are ...
Breaking Medicine News(10 mins):Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2
... ... quarter of fiscal 2009, a 26% ... Strong sales to pharmaceutical manufacturers and retail market customers ... quarter - Strong operating leverage drives bottom-line expansion, ...
... Support New Ambulatory Musculoskeletal Center, NEW YORK, ... New York,s,philanthropic, business, government, medical and civic communities ... Steven A. Stuchin,and long-serving board member and philanthropist ... (NYUHJD) 2008 Founders Gala. This event at the,Waldorf=Astoria ...
... Kris Clark, Ph.D., offers easy tips ... fun - Halloween!, WASHINGTON, Oct. 27 If this ... five to thirteen years, are,poised to don costumes to go ... sweet treats, registered dietitian Kris Clark,Ph.D., of Pennsylvania State University, ...
... Care Knowledge Releases Study on the Value of ... Consumer-Directed Health ... released by,the WellPoint Institute of Health Care Knowledge (Institute) today,researchers ... second study released by the Institute, entitled,"Employers and Consumers Recognize ...
... has received the first annual Vision Award for Business Impact for ... speed of demographic and clinical healthcare data. , ... ... processing healthcare data, think fast. , , , , ,LifeMasters ...
... Statins, the class of drugs commonly used for lowering ... thrombosis (DVT) or blood clots, an affliction that occurs ... presented at CHEST 2008, the 74th annual international scientific ... suggests that the use of statins may be associated ...
Cached Medicine News:Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 2Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 3Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 4Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 5Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 6Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 7Health News:Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009 8Health News:Norma Smith and Dr. Steven A. Stuchin honored at 2008 Founders Gala for NYU Hospital for Joint Diseases 2Health News:No Trick to Halloween Sweet Treats 2Health News:No Trick to Halloween Sweet Treats 3Health News:Research Shows Consumer-Directed Health Plans Encourage Preventive Care 2Health News:Research Shows Consumer-Directed Health Plans Encourage Preventive Care 3Health News:LifeMasters Receives 2008 Vision Award for Business Impact 2Health News:LifeMasters Receives 2008 Vision Award for Business Impact 3Health News:Statins show promise for blood clot prevention 2
... is a microprocessor-controlled programmable power supply ... current and high current/low voltage applications ... is ideal for sample fractionation, IPG ... The low voltage/high current section is ...
... modified battery chargers are ... for GENIE blotters. They ... very specific voltages, giving ... laboratory power supplies. 110 ...
Inquire...
... Elchrom Scientific PSE Power Supply . ... provides 200 V and 2 A in 1 ... possible to run up to three SEA 2000® ... of programmed preset and actual values of voltage, ...
Medicine Products: